+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Positron Emission Tomography (PET): Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5028132

Global Positron Emission Tomography (PET) Market to Reach $759.2 Million by 2027


In the changed post COVID-19 business landscape, the global market for Positron Emission Tomography (PET) estimated at US$725.6 Million in the year 2020, is projected to reach a revised size of US$759.2 Million by 2027, growing at a CAGR of 0.6% over the analysis period 2020-2027. PET-CT, one of the segments analyzed in the report, is projected to record a 0.6% CAGR and reach US$697.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the PET-MR segment is readjusted to a revised 2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $211.8 Million, While China is Forecast to Grow at 0.4% CAGR


The Positron Emission Tomography (PET) market in the U.S. is estimated at US$211.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$134.6 Million by the year 2027 trailing a CAGR of 0.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 0.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.5% CAGR.

Other Product Types Segment to Record 1% CAGR


In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$16.6 Million in the year 2020 will reach a projected size of US$17.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 42 Featured) -
  • Advanced Accelerator Applications SA
  • Best ABT Molecular Imaging, Inc.
  • Curasight A/S
  • Digiray Corporation
  • DuchemBio, Co., Ltd.
  • GE Healthcare
  • Hitachi Ltd.
  • Neusoft Corporation
  • PETsys Electronics SA
  • Philips Healthcare

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Positron Emission Tomography (PET) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Positron Emission Tomography (PET) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Positron Emission Tomography (PET) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for PET-CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for PET-CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for PET-CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for PET-MR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for PET-MR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for PET-MR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 25: World Positron Emission Tomography (PET) Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 27: USA Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 28: USA 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 29: USA Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: USA Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 31: USA 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 33: Canada Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 34: Canada 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 35: Canada Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Canada Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 37: Canada 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
JAPAN
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 39: Japan Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 40: Japan 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 41: Japan Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: Japan Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 43: Japan 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
CHINA
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 45: China Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 46: China 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 47: China Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: China Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 49: China 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
EUROPE
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 51: Europe Historic Review for Positron Emission Tomography (PET) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 52: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
  • Table 53: Europe Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: Europe Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 55: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 56: Europe Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 57: Europe Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 58: Europe 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
FRANCE
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: France Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 61: France 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 62: France Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 63: France Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 64: France 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
GERMANY
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Germany Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 67: Germany 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 68: Germany Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 69: Germany Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 70: Germany 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 72: Italy Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 73: Italy 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 74: Italy Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 75: Italy Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 76: Italy 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 78: UK Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 79: UK 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 80: UK Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 81: UK Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 82: UK 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 84: Rest of Europe Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 85: Rest of Europe 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 87: Rest of Europe Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 88: Rest of Europe 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
  • Positron Emission Tomography (PET) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 91: Asia-Pacific 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 94: Asia-Pacific 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
REST OF WORLD
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 96: Rest of World Historic Review for Positron Emission Tomography (PET) by Product Type - PET-CT, PET-MR and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 97: Rest of World 15-Year Perspective for Positron Emission Tomography (PET) by Product Type - Percentage Breakdown of Value Sales for PET-CT, PET-MR and Other Product Types for the Years 2012, 2021 & 2027
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 99: Rest of World Historic Review for Positron Emission Tomography (PET) by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 100: Rest of World 15-Year Perspective for Positron Emission Tomography (PET) by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2012, 2021 & 2027
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Advanced Accelerator Applications SA
  • Best ABT Molecular Imaging, Inc.
  • Curasight A/S
  • Digiray Corporation
  • DuchemBio, Co., Ltd.
  • GE Healthcare
  • Hitachi Ltd.
  • Neusoft Corporation
  • PETsys Electronics SA
  • Philips Healthcare